EMA begins rolling reviews for a COVID-19 therapeutic and a vaccine

Retrieved on: 2021-05-11 10:52:30

Tags for this article:

COVID-19

Health sciences

COVID-19 vaccines

Clinical trials

Drugs

Monoclonal antibodies

RNA vaccines

COVID-19 drug development

European Medicines Agency

Pfizer-BioNTech COVID-19 vaccine

COVID-19 vaccine

Marketing Authorisation Application

Click the tags to see associated articles and topics

EMA begins rolling reviews for a COVID-19 therapeutic and a vaccine. View article details on hiswai:

Excerpt

Sotrovimab is a monoclonal antibody with activity against COVID-19. It is designed to attach to the Spike (S) protein of SARS-CoV-2 virus, limiting its ...

Article found on: www.europeanpharmaceuticalreview.com

View Original Article